Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

49.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimized seasonal influenza mRNA vaccine compositions demonstrate safety and enhanced immunogenicity in a phase 2 study.

Human vaccines & immunotherapeutics·2026
Same author

HIV-specific and resistant CAR T cells promote control of HIV replication in people with HIV.

Research square·2026
Same author

Perceptions of young people living with HIV and caregivers in Botswana on analytical treatment interruption studies: a qualitative approach.

HIV research & clinical practice·2026
Same author

Proviral HIV-1 DNA Below Detection in Early Treated Adolescents After Prior Treatment Interruption.

Journal of acquired immune deficiency syndromes (1999)·2026
Same author

Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control.

Nature immunology·2026
Same author

Unraveling the root causes of HIV-1 persistence.

Current opinion in HIV and AIDS·2026

Related Experiment Video

Updated: Feb 17, 2026

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
10:18

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

12.8K

Recent progress in understanding HIV reservoirs.

Hsiao-Hsuan Kuo1,2,3, Mathias Lichterfeld1,2,3

  • 1Infectious Disease Division, Brigham and Women's Hospital, Boston.

Current Opinion in HIV and AIDS
|December 13, 2017
PubMed
Summary

Despite effective HIV-1 treatment, infected cells persist, forming viral reservoirs. Understanding these reservoirs, particularly in CD4 T cells, is key to developing a cure for HIV-1.

More Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

3.0K
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

32.2K

Related Experiment Videos

Last Updated: Feb 17, 2026

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
10:18

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

12.8K
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

3.0K
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

32.2K

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Persistent reservoirs of HIV-1-infected cells are the primary obstacle to a cure, even with effective antiretroviral therapy.
  • Understanding the diversity and complexity of these viral reservoirs is crucial for developing eradication strategies.

Purpose of the Study:

  • To review recent advancements in understanding the complexity and diversity of HIV-1 viral reservoir cells.
  • To explore the cellular compartments and mechanisms contributing to long-term viral persistence.

Main Methods:

  • Review of current literature on HIV-1 viral reservoirs.
  • Analysis of studies investigating phenotypic markers and molecular profiling of infected cells.
  • Examination of novel assays for reservoir quantification.

Main Results:

  • Latently infected memory CD4 T cells are the main reservoir, but myeloid cells and hematopoietic progenitors may also contribute.
  • Specific T-cell markers can identify cells with replication-competent HIV-1.
  • Clonal proliferation of infected CD4 T cells stabilizes the viral reservoir.

Conclusions:

  • Technological advances enable detailed profiling of viral reservoir cells.
  • Understanding reservoir properties offers insights for novel interventions to eliminate HIV-1 persistence during therapy.